Giuseppe Lembo1,2. Show Affiliations » 1. Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy. 2. Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, 86077 Pozzilli, Italy.
Abstract
Entities: Disease Species
Mesh： See more » Anti-Inflammatory Agents/adverse effectsAnti-Inflammatory Agents/therapeutic useAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAtherosclerosis/bloodAtherosclerosis/diagnosisAtherosclerosis/drug therapyAtherosclerosis/immunologyBiomarkers/bloodC-Reactive Protein/metabolismEvidence-Based Medicine/methodsHumansInflammation Mediators/bloodMyocardial Infarction/bloodMyocardial Infarction/diagnosisMyocardial Infarction/drug therapyMyocardial Infarction/immunologyRandomized Controlled Trials as TopicRecurrenceRisk FactorsSecondary Prevention/methodsTreatment Outcome
Substances： See more » Anti-Inflammatory AgentsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBiomarkersInflammation MediatorscanakinumabC-Reactive Protein
Year: 2018 PMID： 29293914 DOI： 10.1093/cvr/cvx219
Source DB: PubMed Journal: Cardiovasc Res ISSN： 0008-6363 Impact factor: 10.787